FDAReview.org

FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression

Raymond March - March 28, 2019

Generic Insulin Now Available After Nearly One Hundred Years of Regulatory Protection From Competition

March 25, 2019

FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?

March 14, 2019

FDA Panel Backs Ketamine-Based Treatment for Depression

March 1, 2019

What's New

Let Competition, Not Politicians, Bring Insulin Prices Down

Raymond March - February 20, 2019

Right-to-try Laws Help Patient with Terminal Brain Cancer

Raymond March - February 1, 2019

FDA Approves Record Number of Generic Drugs in 2018

Raymond March - January 9, 2019

Teen Vaping Is Bad, but the Alternative Is Worse

Raymond March - January 8, 2019

Can the FDA Prevent Teens from Vaping?

Raymond March - January 4, 2019

Deregulation Is the Only Cure for High Drug Prices

Raymond March - January 3, 2019

FDA Vaping Regulations Will Do More Harm than Good

Raymond March - November 30, 2018

To Help the Terminally Ill, the FDA Must Deregulate

Raymond March - November 14, 2018

When Healthy Policy Neglects Economic Principles, Patients Suffer

Raymond March - October 13, 2018

FDA Still Hooked on Meddling in Nicotine Markets

October 8, 2018

FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple...

September 26, 2018

Let Competition, Not the FDA, Resolve the EpiPen Shortage

September 12, 2018

Government vs. Private Efforts to Promote Breastfeeding: My Response to a...

September 2, 2018